Banner for leaf pages 2

Rivaroxaban (Xarelto)

Also known as Xarelto

Rivaroxaban (BAY 59-7939) is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects lasts 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible. There is no specific way to reverse the anticoagulant effect of rivaroxaban in the event of a major bleeding event, unlike warfarin.

Source: Wikipedia

What is it prescribed for?

Patients are most commonly prescribed rivaroxaban to treat rabies, blastomycosis, west nile virus, and pick disease.

Ajax-loader Loading...